Looking forward, the GLP-1 drugs we study (semaglutide, tirzepatide, and emerging oral formulations like orforglipron) are likely only the beginning of a new wave of chronic therapies for conditions like obesity, heart failure, and even kidney disease
Benefits of Compounded Tirzepatide Found members on compounded tirzepatide lose 33% more weight than on compounded semaglutide, on average 12% in 6 months.* Tirzepatide's dual mechanism may support weight loss in people who haven't responded well to GLP-1only options, because it works through two separate pathways rather than one
individuals allergic to peptide components
This change makes the molecule too hydrophilic to cross BBB, therefore high dose is needed for CNS application [16]
This product is not intended to diagnose, treat, cure, or prevent any disease." That language is present and confirms the product's status as a dietary supplement under DSHEA - not a pharmaceutical